Tissue Engineering
Regentis Biomaterials Advances Simplified Cartilage Repair Platform Toward Key Milestones
Regentis Biomaterials is moving its cell-free hydrogel implant GelrinC toward U.S. market entry, targeting a $3 billion knee cartilage repair market with a simplified procedure that could replace traditional microfracture and cell-based therapies.
Regentis Biomaterials Advances Cell-Free Knee Cartilage Implant, Targeting Major Market Gap
Regentis Biomaterials is advancing GelrinC, a ready-to-use hydrogel implant for knee cartilage repair, addressing a U.S. market of approximately 470,000 annual cases lacking an approved off-the-shelf regenerative solution.
Regentis Biomaterials Targets Major Gap in Knee Cartilage Repair with Off-the-Shelf Implant
Regentis Biomaterials Ltd. is advancing GelrinC, a cell-free hydrogel implant for knee cartilage repair, which could address a significant unmet need in the U.S. market where no off-the-shelf regenerative solution currently exists.
BioStem Technologies to Present at LD Micro Invitational, Highlighting Regenerative Medicine Advances
BioStem Technologies will present at the 16th Annual LD Micro Invitational, showcasing its proprietary allograft technologies and expanding presence in regenerative medicine.